Clinical Trial

Personalized Evaluation of Susptected Myocardial Ischemia

Study acronym: PERMI
Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to assess whether the use of clinical risk models, known as Clinical Likelihood (CL) models, can reduce the need for diagnostic examinations without negatively impacting quality of life or prognosis after 12 months in patients with stable new onset chest pain. Additionally, the project will evaluate a newly developed method called Laser Speckle Contrast Imaging for measuring function and oxygen content in the smallest blood vessels (microvasculature) of the hand, which may also reflect blood flow and oxygen content in the microvasculature of the heart.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-24; most recent amendment 2025-12-12.
Trial Details
NCT Number NCT06708000
Lead Sponsor Gødstrup Hospital
Conditions Chronic Coronary Syndrome, Angina Pectoris, Coronary Artery Disease, Myocardial Ischemia, Arteriosclerosis
Enrollment 2,000 participants
Start Date 2024-11-20
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-19